➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Moodys
Express Scripts
Merck
Boehringer Ingelheim

Last Updated: March 2, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Lymecycline

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Lymecycline?

Lymecycline is an investigational drug.

There have been 3 clinical trials for Lymecycline. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2010.

The most common disease conditions in clinical trials are Uterine Cervicitis, Urethritis, and Pleuropneumonia. The leading clinical trial sponsors are Ostergotland County Council, Sweden, Statens Serum Institut, and Galderma.

Recent Clinical Trials for Lymecycline
TitleSponsorPhase
Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment CommencedStatens Serum InstitutPhase 4
Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment CommencedOstergotland County Council, SwedenPhase 4
Comparison of Epiduo Associated With Lymecycline Versus Epiduo Vehicle Associated With Lymecycline in Acne VulgarisGaldermaPhase 3

See all Lymecycline clinical trials

Clinical Trial Summary for Lymecycline

Top disease conditions for Lymecycline
Top clinical trial sponsors for Lymecycline

See all Lymecycline clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Moodys
Express Scripts
Merck
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.